{"symbol": "CHMA", "companyName": "Chiasma Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.chiasmapharma.com", "description": "Chiasma Inc is a biopharmaceutical company which focuses on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases.", "CEO": "Mark J. Fitzpatrick", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}